Jinzhen Oral Liquid alleviates lipopolysaccharide-induced acute lung injury through modulating TLR4/MyD88/NF-κB pathway
Yaling Li, Shu-Yan Qin, Qian Li, Shao‐Jiang Song, Wei Xiao, Guo‐Dong Yao
Topics & Concepts
TLR4Western blotLipopolysaccharideTumor necrosis factor alphaPharmacologyImmunofluorescenceChemistryMedicineIn vivoNF-κBApoptosisBlotInflammationImmunologyAntibodyBiologyBiochemistryBiotechnologyGeneImmune Response and InflammationChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and Mechanisms